Invention Grant
- Patent Title: GABA analog prodrug sustained release oral dosage forms
- Patent Title (中): GABA类似物前药缓释口服剂型
-
Application No.: US11269045Application Date: 2005-11-03
-
Publication No.: US08795725B2Publication Date: 2014-08-05
- Inventor: Kenneth C. Cundy , Srikonda Sastry , Manshiu Leung , Balaji V. Kadri , Paul E. Stach
- Applicant: Kenneth C. Cundy , Srikonda Sastry , Manshiu Leung , Balaji V. Kadri , Paul E. Stach
- Applicant Address: US CA Santa Clara
- Assignee: XenoPort, Inc.
- Current Assignee: XenoPort, Inc.
- Current Assignee Address: US CA Santa Clara
- Agency: Polsinelli PC
- Main IPC: A61K9/22
- IPC: A61K9/22
Abstract:
Sustained release oral dosage forms of a gabapentin prodrug, 1-{[(α-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective.
Public/Granted literature
- US20060141034A1 GABA analog prodrug sustained release oral dosage forms Public/Granted day:2006-06-29
Information query
